{
    "root": "69d27397-b1ca-4f9d-9fe0-33799a88b4f2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Pirfenidone",
    "value": "20250306",
    "ingredients": [
        {
            "name": "PIRFENIDONE",
            "code": "D7NLD2JX7U"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "Pirfenidone tablets are indicated for the treatment of idiopathic pulmonary fibrosis (IPF).",
    "contraindications": "• Take with food. • Recommended dosage: 801 mg three times daily (2403 mg/day). (2) • Upon initiation of treatment, titrate to the full dosage of 2403 mg/day over a 14-day period as follows: Treatment days Dosage Days 1 through 7 267 mg three times daily (801 mg/day) Days 8 through 14 534 mg three times daily (1602 mg/day) Days 15 onward 801 mg three times daily (2403 mg/day) • Consider temporary dosage reduction, treatment interruption, or  discontinuation for management of adverse reactions. (2.3, 5.1,  5.2, 5.3, 5.4) • Prior to treatment, conduct liver function tests. (2.1)",
    "warningsAndPrecautions": "Pirfenidone tablets are available in 267 mg strength and are supplied in bottles as follows:\n                  267 mg tablets: Yellow, oval, biconvex, film coated tablet, debossed with “L” on one side and “749” on other side.\n                  NDC: 72162-2465-2: Carton containing 3 bottles, each containing ninety 267 mg tablets (270 tablets total)\n                  Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n                  Keep the bottle tightly closed. Do not use if the seal over the bottle opening is broken or missing. Safely throw away any pirfenidone tablets that are out of date or no longer needed.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions": "None."
}